Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

John Wells

Physician Assistant Gallipolis, OH Physician Assistant

NPI 1831119791 CMS profile 11133000

100 Jackson Pike, Gallipolis, OH 45631

Open in the dashboard

General payments

$3,280

230 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Wells of Gallipolis, OH is reported in the CMS Open Payments database as having received $3,280 across 230 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $858 55
2024 General $567 32
2023 General $729 54
2022 General $899 74
2021 General $227 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Wells
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to John Wells were reported at $858. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year John Wells Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $227 $132 $37–$438 $132
2022 $899 $155 $48–$522 $149
2023 $729 $167 $52–$557 $160
2024 $567 $178 $55–$600 $164
2025 $858 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $887 88 payments
  2. Novartis Pharmaceuticals Corporation $431 25 payments
  3. Pfizer Inc. $257 17 payments
  4. Janssen Pharmaceuticals, Inc $236 15 payments
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $232 11 payments
  6. Amgen Inc. $211 12 payments
  7. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $176 12 payments
  8. Novo Nordisk Inc $146 8 payments
  9. Baxter Healthcare $120 7 payments
  10. Medtronic, Inc. $81 6 payments
  11. Other $504 29 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,280 230 payments
Products named General payments · program years 2021–2025
  1. XIENCE SIERRA $548 53 payments
  2. ELIQUIS $257 17 payments
  3. LEQVIO $254 15 payments
  4. XARELTO $236 15 payments
  5. Repatha $191 11 payments
  6. ENTRESTO $177 10 payments
  7. JARDIANCE $177 8 payments
  8. LifeVest $176 12 payments
  9. XIENCE SKYPOINT Structural Heart $150 15 payments
  10. Xience Skypoint Vascular $114 13 payments
  11. Other $1,180 73 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

161

Median for Physician Assistant: 241

Drug cost

$21,213

Median for Physician Assistant: $4,110

Branded share of claims

29.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 35 $20,354
Metoprolol Succinate Generic 54 $633
Atorvastatin Calcium Generic 11 $93
Carvedilol Generic 26 $74
Metoprolol Tartrate Generic 23 $46
Isosorbide Mononitrate Er Isosorbide Mononitrate Brand 12 $11

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$23,861

Medicare's payments for the services billed

Medicare patients

342

Average age 78

Services billed

1,077

181 women, 161 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 58%
Arthritis 58%
Heart failure 50%
Atrial fibrillation 48%
Diabetes 46%
Chronic kidney disease 41%
COPD 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Repatha
  • Amgen Inc. $108
$108 — —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $90
$90 — —
ELIQUIS
  • PFIZER INC. $53
$53 35 —
LEQVIO
  • Novartis Pharmaceuticals Corporation $48
$48 — —
XARELTO
  • Janssen Pharmaceuticals, Inc $39
$39 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

230 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record